Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms

ClinicalTrials.gov ID: NCT03448419

Public ClinicalTrials.gov record NCT03448419. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 5:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Randomised, Double-blind Trial to Evaluate the Effect of 12 Weeks Treatment of Once Daily EMPagliflozin 10 mg Compared With Placebo on ExeRcise Ability and Heart Failure Symptoms, In Patients With Chronic HeArt FaiLure With Reduced Ejection Fraction (HFrEF) (EMPERIAL-reduced)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of the study is to evaluate the effect of empagliflozin 10 mg versus placebo on exercise ability using the 6 minute walk test in patients with chronic HF with reduced ejection fraction (LVEF ≤ 40%) Secondary objectives are to assess Patient-Reported Outcome (PRO)

Study identification

NCT ID
NCT03448419
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Boehringer Ingelheim
Industry
Enrollment
312 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 20, 2018 (Actual)
Primary completion
Sep 30, 2019 (Actual)
Completion
Oct 7, 2019 (Actual)
Last update posted
Nov 27, 2020

2018 – 2019

United States locations

U.S. sites
41
U.S. states
24
U.S. cities
40
Facility City State ZIP Site status
Mobile Heart Specialists, PC Mobile Alabama 36608 —
The Center for Clinical Trials, Inc. Saraland Alabama 36571 —
California Heart Specialists Huntington Beach California 92648 —
Manshadi Heart Institute, Inc Stockton California 95204 —
University of California Los Angeles Torrance California 90502 —
University of Colorado Denver Aurora Colorado 80045 —
Western Connecticut Health Network Danbury Connecticut 06810 —
Infinite Clinical Research Miami Florida 33133 —
Advance Medical Research Center Miami Florida 33135 —
Bio1 Clinical Research Miami Beach Florida 33140 —
Pharmacology Research, LLC North Miami Beach Florida 33169 —
Palm Beach Gardens Research Center, LLC Palm Beach Gardens Florida 33410 —
East Coast Institute for Research, LLC Saint Augustine Florida 32086 —
Cozy Research LLC Zephyrhills Florida 33541 —
Grady Memorial Hospital Atlanta Georgia 30303 —
Georgia Arrhythmia Consultants and Research Institute Warner Robins Georgia 31093 —
St Luke's Clinic - Idaho Cardiology Associates Boise Idaho 83712 —
Northwest Heart Clinical Research, LLC Arlington Heights Illinois 60005 —
Clinical Investigation Specialists, Inc Gurnee Illinois 60031 —
Chicago Medical Research Hazel Crest Illinois 60429 —
Midwest Heart and Vascular Specialists Overland Park Kansas 66211 —
Grace Research, LLC Bossier City Louisiana 71111 —
Grace Research, LLC Shreveport Louisiana 71107 —
Clinical Trials of America LA, LLC West Monroe Louisiana 71291 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
University Of Mississippi Medical Center Jackson Mississippi 39216 —
Med Research One Florissant Missouri 63031 —
The DOCS Las Vegas Nevada 89113 —
Rutgers Robert Wood Johnson Medical School New Brunswick New Jersey 08901 —
New York Heart Research Foundation, Inc. Mineola New York 11501 —
PMG Research of Rocky Mount, LLC Rocky Mount North Carolina 27804 —
PMG Research of Wilmington, LLC Wilmington North Carolina 28401 —
Rama Research LLC Marion Ohio 43302 —
Columbia Heart Clinic Columbia South Carolina 29203 —
Black Hills Cardiovascular Research Rapid City South Dakota 57701 —
The Jackson Clinic, PA Jackson Tennessee 38301 —
DiscoveResearch, Inc. Beaumont Texas 77701 —
Angiocardiac Care of Texas Houston Texas 77025 —
Mary Washington Hospital Research Department Fredericksburg Virginia 22401 —
York Clinical Research, LLC Norfolk Virginia 23510 —
Aspirus Research Institute Wausau Wisconsin 54401 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 68 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03448419, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 27, 2020 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03448419 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →